+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia



Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia



Evidence-Based Mental Health 5(4): 113




(PDF emailed within 0-6 h: $19.90)

Accession: 046210312

Download citation: RISBibTeXText

PMID: 12440454

DOI: 10.1136/ebmh.5.4.113


Related references

Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia. Acta Psiquiatrica Y Psicologica de America Latina 35(3-4): 111-115, 1989

Disposition of Haloperidol and Reduced Haloperidol Plasma Levels After Single Dose Haloperidol Decanoate Administration. Human Psychopharmacology. 10(1): 47-51, 1995

Haloperidol and reduced haloperidol plasma concentrations after a loading dose regimen with haloperidol decanoate. Progress In Neuro-Psychopharmacology & Biological Psychiatry. 20(1): 73-86, 1996

12-month study of haloperidol decanoate in chronic schizophrenic patients. International Pharmacopsychiatry 17(4): 247-254, 1982

Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics. Progress in Neuro-Psychopharmacology & Biological Psychiatry 17(1): 105-112, 1993

Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia a double blind multicenter study. Acta Psychiatrica Scandinavica 84(1): 14-21, 1991

A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. Journal of Clinical Psychopharmacology 9(4): 247-253, 1989

Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Acta Psychiatrica Belgica 82(2): 216-223, 1982

Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison. Acta Psychiatrica Scandinavica 74(3): 255-262, 1986

Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia. Psychopharmacology 102(4): 514-520, 1990

A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Psychopharmacology Bulletin 20(1): 108-109, 1984

Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal. Psychopharmacology 169(1): 28-34, 2003

Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Journal of Clinical Psychiatry 66(8): 1021-1030, 2005